| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.031 | 0.5 |